BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30962721)

  • 1. UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.
    Ye Y; Huang S; Wu Y
    Cancer Manag Res; 2019; 11():2339-2348. PubMed ID: 30962721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathway.
    Shi X; Yang L; Xie J; Zhao Y; Cong J; Li Z; Li H; Cheng X; Fan J
    Mol Med Rep; 2018 Sep; 18(3):3382-3388. PubMed ID: 30066877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway.
    Wang Q; Shi W
    Oncol Lett; 2019 Mar; 17(3):2976-2982. PubMed ID: 30854075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UNBS5162 inhibits colon cancer growth via suppression of PI3K/Akt signaling pathway.
    Zhang F; Lv HZ; Liu JM; Ye XY; Wang CC
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():99-104. PubMed ID: 30403183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway.
    Li HH; Song XX; Liu B; Yang WP
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1306-1312. PubMed ID: 30995142
    [No Abstract]   [Full Text] [Related]  

  • 6. UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis.
    Liu C; Xing J; Gao Y
    Thorac Cancer; 2018 Jan; 9(1):105-111. PubMed ID: 29130641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway.
    He D; Zhang S
    Mol Med Rep; 2018 Jan; 17(1):549-555. PubMed ID: 29115622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis.
    Wang B; Shen J; Wang J
    Onco Targets Ther; 2017; 10():5303-5309. PubMed ID: 29158682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    Li X; Li Z; Li X; Liu B; Liu Z
    BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
    Mijatovic T; Mahieu T; Bruyère C; De Nève N; Dewelle J; Simon G; Dehoux MJ; van der Aar E; Haibe-Kains B; Bontempi G; Decaestecker C; Van Quaquebeke E; Darro F; Kiss R
    Neoplasia; 2008 Jun; 10(6):573-86. PubMed ID: 18516294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells.
    Yue X; Li M; Chen D; Xu Z; Sun S
    Exp Ther Med; 2018 Nov; 16(5):3921-3928. PubMed ID: 30344670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
    Yao X; Jiang W; Yu D; Yan Z
    Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway.
    Dang N; Meng X; Ma S; Zhang Q; Sun X; Wei J; Huang S
    Open Med (Wars); 2018; 13():416-424. PubMed ID: 30613786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway.
    Liu W; Yu Q; Wang F; Li Y; Zhang G; Tao S
    Hum Exp Toxicol; 2022; 41():9603271211069034. PubMed ID: 35128947
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo.
    Li M; Zhu Y; Bai B; Fang J; Yao W; Li Y; Li S; Li X; Jin N; Jiang R
    Cancer Biomark; 2021; 32(3):251-262. PubMed ID: 34459386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroline-5-carboxylate reductase 1 promotes cell proliferation via inhibiting apoptosis in human malignant melanoma.
    Ye Y; Wu Y; Wang J
    Cancer Manag Res; 2018; 10():6399-6407. PubMed ID: 30568501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet-1 promotes the proliferation and invasion, and inhibits the apoptosis of A375 human melanoma cells.
    Zhu X; Li Y; Meng Q
    Int J Mol Med; 2018 Jun; 41(6):3680-3690. PubMed ID: 29568936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Hedgehog Signaling Pathway on the Proliferation and Apoptosis of Melanoma Cells.
    Peng ZP; Huang SF; Li JJ; Tang XK; Wang XY; Li HM
    J Oncol; 2022; 2022():4984866. PubMed ID: 35027924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.